Atlas Trials

Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in Neonates

Clinical trial NCT02598648 · UNKNOWN

Trial details

NCT number
NCT02598648
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Respiratory Distress SyndromeAcute Lung InjuryFXRRIPK3
Start date
2015-09-20
Primary completion
2023-09-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.